Binance Labs announced an investment in BIO Protocol, aimed at promoting patient-led scientific research while accelerating the expansion of the BioDAO ecosystem.
Author: BIO Protocol
Translated by: Deep Tide TechFlow
In November, the BIO.xyz ecosystem saw several exciting developments. From Binance Labs' first DeSci (Decentralized Science) investment, to in-depth discussions between CZ and Vitalik, to VitaDAO launching its first longevity product, pump.science's RIF and URO flight experiments, as well as Long COVID Labs starting participant recruitment screening, upgrades to BIO Launchpad, AthenaDAO's fertility research, the opening and patent applications of HairDAO Labs, the launch of new IP-Tokens, and VitaRNA's in vivo testing, the BIO.xyz ecosystem is rapidly driving the decentralized revolution in scientific research!
Here are the core highlights of this month:
Binance Labs' first DeSci investment
Binance Labs announced an investment in BIO Protocol, aimed at promoting patient-led scientific research while accelerating the expansion of the BioDAO ecosystem.
[Click to view the full announcement]
A few days later, Binance Labs and BIO jointly hosted the DeSci Builders event, attended by CZ and Vitalik.
(Tweet details)
At the event, Vitalik showcased VD001, the first longevity product launched by VitaDAO—a natural high-dose spermidine supplement approved by the Thai FDA.
After the event, the auction for BIO Genesis quickly reached its cap, ultimately raising over $33 million in contribution funds. Track the BIO treasury.
(Tweet details)
DeSci 2.0: BIO leads the biotechnology revolution
BIO co-founder Paul Kohlhaas released the latest vision for BIO Protocol. He detailed upcoming features, including the establishment of new BioDAOs, upgrades to the BIO Launchpad, and the public release of the BIO Token.
(Tweet details) Paul also wrote a lengthy thread on DeSci based on his speech at the DeSci Bangkok conference, further elaborating on the potential and direction of DeSci 2.0.
Click here to view Paul's speech at DeSci in Bangkok.
Upcoming new BioDAO
The BIO Launchpad platform has released a new version, which will serve as the launch platform for the upcoming new BioDAO.
Please pay attention to the following upcoming projects: Long COVID Labs, Quantum Biology DAO, Curetopia.
(Tweet details)
Click to learn more about how BIO operates.
Long COVID Labs begins research qualification screening
Long COVID Labs announced its first therapeutic candidate and officially launched qualification screening for research on combination antiviral drugs.
Want to learn more? Check out the story of how LCL founder Rohan Dixit discovered this treatment solution!
(Tweet details)
Gamified research takes off
pump.science launched a second round of experiments to study whether Rifampicin ($RIF) and Urolithin A ($URO) can extend the lifespan of fruit flies. This experiment quickly garnered widespread attention from the crypto community, and the market performance of both tokens subsequently 'took off.' The market cap of RIF surged from about $250,000 on November 9 to a peak of $230 million on November 18, currently stabilizing around $135 million. This cross-industry combination showcases the innovative potential of scientific research and the crypto economy.
(Tweet details)
Subsequently, VitaDAO announced that it will use the pump.science platform to conduct experiments for its longevity research project VitaFAST, testing new potential compounds:
(Tweet details)
VitaDAO's first longevity product
VitaDAO is collaborating with pump.science and Molecule to develop a new supplement, using active ingredients that have shown lifespan-extending effects in model organism experiments. This product is expected to be a significant breakthrough in the field of longevity technology. [Learn more]
(Tweet details)
VitaRNA live testing begins
VitaRNA will conduct in vivo safety studies of the novel compound Artan-102 in mice. This marks an important step for the VitaRNA project this year, laying the groundwork for further applications of its research results.
Want to learn more? Join the VitaRNA Telegram community for real-time updates.
The IP-NFT project on the Catalyst platform completed full funding
In just 48 hours, the Catalyst platform raised over $1.3 million for six scientific research projects, all of which reached their funding caps. These projects cover cutting-edge fields such as Alzheimer’s disease, brain tissue regeneration, aging, and bioremediation, with participating research institutions including King's College, Tel Aviv University, and the Albert Einstein College of Medicine.
Click to learn more.
ValleyDAO breaks Catalyst funding record
ValleyDAO's first two IPT projects completed full funding on the Catalyst platform in just 26 minutes, setting a new record.
Among them, KardaForge's bioremediation technology is expected to provide significant support for the AI and electric vehicle (EV) industries by converting electronic waste into critical metals.
Click to learn more.
Meanwhile, HempKnit is developing more sustainable and durable hemp fibers to address environmental issues caused by fast fashion.
Click to learn more.
AthenaDAO's first IPT project
AthenaDAO launched its first IPT project based on Dr. Mario Cordero's groundbreaking discoveries in studying ovarian aging through the cGAS-STING pathway and cellular aging mechanisms.
Join the project now.
Nisi Ovaria
AthenaDAO is collaborating with Gero to tokenize research on genetic targets related to ovarian aging using AI technology, aiming to develop innovative drugs that can delay menopause.
Explore upcoming projects from Nisi Ovaria.
CerebrumDAO derivative project
CerebrumDAO will provide funding support for a new project by Fission Pharma, aimed at developing a P110 analog capable of penetrating the blood-brain barrier. This project's funding will be raised through IP-NFT and IPT mechanisms.
Click here to learn more.
PsyDAO's IPT project
PsyDAO launched a new IPT project aimed at developing safer and more effective empathogens for mental health treatment by designing molecules with effects similar to MDMA but fewer side effects.
Learn more.
CryoRat research is about to start
CryoDAO is preparing to launch an important low-temperature preservation research project, stay tuned for upcoming developments!
